Dr. Sahithi Chittamuri, MD

Dr. Chittamuri practices at Tift Regional Medical Center in Tifton, Georgia, part of Southwell.

Dr. Chittamuri's NPI, 1083147623, was assigned on April 11, 2017. Dr. Chittamuri holds Georgia license 94480.

Dr. Chittamuri's primary practice is Tift Regional Medical Center, at 901 E 18th Street, Tifton, GA 31794 in Tift County. The practice phone is (229) 382-7120.

Dr. Chittamuri's primary practice is Tift Regional Medical Center in Tifton, Georgia, part of Southwell. Dr. Chittamuri is also affiliated with Phoebe Putney Memorial Hospital. The medical group on file is Tift Regional Health System. Dmand AI also links Dr. Chittamuri to 1 more hospital, 1 breast imaging center and 1 medical group, each named with a free account. Dr. Chittamuri's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chittamuri practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chittamuri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chittamuri is licensed in Georgia.

CMS data shows 451 Medicare services from Dr. Chittamuri across 5 procedure codes in 2024, for 129 Medicare patients. Medicare paid $36,494 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Dr. Chittamuri in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chittamuri's median patient age at 71, with 62% women.

In 2024, Dr. Chittamuri wrote 1,076 Medicare Part D claims for 172 patients. 87% of them were for generic drugs. CMS names the drug for 832 of them, across 27 drugs with 11 or more claims each, at $1,029,674 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Chittamuri for performance year 2024, reported as part of a group. Dr. Chittamuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Chittamuri, published from 2021 to 2022. 2022 was the busiest year, with 3. Dr. Chittamuri has published most often in Cureus. Dr. Chittamuri's most frequent co-authors are Hamid Salim Shaaban, MD, Mina Effat Fransawy Alkomos, MD and Gowthami Are, MD.

CMS Open Payments shows 20 general payments to Dr. Chittamuri from 10 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 84% of the total. Gilead Sciences, Inc. paid the most, $185.